DLA Piper advised Pengana on the deal. Pengana Capital Group Ltd (ASX:PCG) (Pengana) and its subsidiary Pengana Credit Pty Ltd (Pengana Credit) completed the structuring and...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised the joint sponsors on the deal while O’Melveny represented Sipai Health Technology Co., Ltd, Eight Roads and F-Prime. The joint sponsors Morgan Stanley...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised the underwriters on the deal while O’Melveny represented OrbusNeich Medical Group. OrbusNeich Medical Group Holdings Limited (6929.HK) announced its approximate US$61.6 million (approximately HK$481...
You must be a Standard 1 Year member to access this content.
O’Melveny advised the sponsors and underwriters on the listing, while Wilson Sonsini Goodrich & Rosati and Maples and Calder represented Huafang. Huafang Group Inc. announced the IPO...
You must be a Standard 1 Year member to access this content.
O’Melveny recently represented Central China Real Estate Limited and its controlling shareholder, Joy Bright Investments Limited, on the deal. Central China Real Estate Limited (CCRE) (0832.HK)...
You must be a Standard 1 Year member to access this content.
O’Melveny represented China International Capital Corporation Hong Kong Securities Limited (CICC) and China Industrial Securities International Capital Limited on the deal. China International Capital Corporation Hong...
You must be a Standard 1 Year member to access this content.
Sidley represented Lushang Life Services Co., Ltd. on the deal while O’Melveny advised ABCI Capital Limited and China International Capital Corporation Hong Kong Securities Limited. Lushang...
You must be a Standard 1 Year member to access this content.
Slaughter and May, Hong Kong, acted for China International Capital Corporation Hong Kong Securities Limited, O’Melveny advised China VAST, while Latham & Watkins represented China Jinmao...
You must be a Standard 1 Year member to access this content.
O’Melveny represented RemeGen Co. on the deal. RemeGen Co., Ltd. (“RemeGen”) (9995.HK; 688331.SH) announced its A-share listing on the Sci-Tech Innovation Board of the Shanghai Stock...
You must be a Standard 1 Year member to access this content.
Paul Hastings advised Kangqiao Service Group Limited on the deal while O’Melveny & Myers represented CCB International Capital Limited as sole sponsor and other underwriters. Kangqiao...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers and Maples and Calder advised Brii Biosciences Limited on the deal. Herbert Smith Freehills has advised Morgan Stanley and UBS. Brii Biosciences Limited...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers LLP advised BOCOM International (Asia) Limited on the deal. BOCOM International (Asia) Limited acted as financial advisor to Qingdao Holdings International Limited (499.HK), in...
You must be a Standard 1 Year member to access this content.
